epothilone E CAS：201049-37-8

2025-4-29

Product Overview of Epothilone E CAS:201049-37-8

Epothilone E CAS:201049-37-8 is a potent antitumor agent that has been extensively studied for its potential in cancer treatment. This guide aims to provide a comprehensive overview of Epothilone E, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this guide, readers will have a clear understanding of Epothilone E and its applications.

Parâmetros do produto

Epothilone E is a natural product extracted from the soil-dwelling fungus. It is a macrocyclic lactone that has been shown to have antitumor activity. The molecular formula of Epothilone E is C44H68O10, and its molecular weight is 816.98 g/mol. The following table provides detailed information about the physical and chemical properties of Epothilone E.

Imóveis	Valor
Fórmula molecular	C44H68O10
Peso molecular	816.98 g/mol
Aparência	Pó cristalino branco a esbranquiçado
Solubilidade	Soluble in DMSO, slightly soluble in ethanol, and almost insoluble in water
Condição de armazenamento	Conservar em local fresco e seco, protegido da luz e da humidade

Cenários de utilização

Epothilone E has been studied for its potential in treating various types of cancer, including lung cancer, breast cancer, and ovarian cancer. The following table lists some of the common usage scenarios of Epothilone E.

Tipo de cancro	Cenário de utilização
Cancro do pulmão	Combination therapy with other antitumor drugs
Cancro da mama	Monotherapy or combination therapy
Cancro do ovário	Monotherapy or combination therapy

Estudos de caso

Here are two case studies of Epothilone E in clinical practice.

Estudo de caso 1: A patient with advanced lung cancer was treated with Epothilone E in combination with other antitumor drugs. The patient showed significant improvement in symptoms and a reduction in tumor size after treatment.

Estudo de caso 2: A patient with breast cancer received Epothilone E as monotherapy. The patient experienced a partial response to the treatment, with a reduction in tumor size and an improvement in overall quality of life.

Soluções

Epothilone E can be used in various treatment regimens, depending on the type and stage of cancer. The following are some common solutions for using Epothilone E in cancer treatment:

Combination therapy with other antitumor drugs
Monotherapy for certain types of cancer
Targeted therapy for specific cancer cells

Opiniões de especialistas

Experts in the field of oncology have conducted extensive research on Epothilone E. The following are some key opinions from experts:

Epothilone E has shown promising antitumor activity in preclinical and clinical studies.
Further research is needed to optimize the dosage and treatment regimen of Epothilone E.
Epothilone E may have fewer side effects compared to other antitumor drugs.

Perguntas frequentes (FQA)

Q: What is the recommended dosage of Epothilone E for cancer treatment? A: The recommended dosage of Epothilone E varies depending on the type and stage of cancer. It is best to consult with an oncologist for personalized dosing recommendations.

Q: Are there any side effects associated with Epothilone E? A: Epothilone E may cause side effects such as nausea, vomiting, and fatigue. These side effects are usually mild to moderate and can be managed with appropriate treatment.

Conclusão

Epothilone E CAS:201049-37-8 is a promising antitumor agent with potential applications in various types of cancer. This guide has provided a comprehensive overview of Epothilone E, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. We hope this guide will help readers gain a better understanding of Epothilone E and its applications in cancer treatment.